ZA202201221B - Cyclopentane compounds - Google Patents

Cyclopentane compounds

Info

Publication number
ZA202201221B
ZA202201221B ZA2022/01221A ZA202201221A ZA202201221B ZA 202201221 B ZA202201221 B ZA 202201221B ZA 2022/01221 A ZA2022/01221 A ZA 2022/01221A ZA 202201221 A ZA202201221 A ZA 202201221A ZA 202201221 B ZA202201221 B ZA 202201221B
Authority
ZA
South Africa
Prior art keywords
cyclopentane compounds
cyclopentane
compounds
medicine
processes
Prior art date
Application number
ZA2022/01221A
Inventor
Xiaolin Zhang
Weitao Pan
Grigorios Nikitidis
Jenny Susanna Marika Lindhagen
Original Assignee
Dizal Jiangsu Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dizal Jiangsu Pharmaceutical Co Ltd filed Critical Dizal Jiangsu Pharmaceutical Co Ltd
Publication of ZA202201221B publication Critical patent/ZA202201221B/en

Links

Abstract

The present invention relates to cyclopentane compounds of Formula (I), physical forms thereof, processes for their production and their use in medicine.
ZA2022/01221A 2018-05-11 2022-01-26 Cyclopentane compounds ZA202201221B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2018086503 2018-05-11

Publications (1)

Publication Number Publication Date
ZA202201221B true ZA202201221B (en) 2024-01-31

Family

ID=90474912

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/01221A ZA202201221B (en) 2018-05-11 2022-01-26 Cyclopentane compounds

Country Status (1)

Country Link
ZA (1) ZA202201221B (en)

Similar Documents

Publication Publication Date Title
PH12017501921A1 (en) Novel compounds
MX2019003735A (en) Dilutable formulations of cannabinoids and processes for their preparation.
MX2018012880A (en) Methods for providing single-stranded rna.
MX2021001186A (en) Purinones as ubiquitin-specific protease 1 inhibitors.
EA201792205A1 (en) HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
SG10201806849WA (en) Cyclopropylamines as lsd1 inhibitors
EA201691594A1 (en) CYCLOPROPYLAMINES AS LSD1 INHIBITORS
SA518391864B1 (en) Bipyrazolyl derivatives useful for the treatment of autoimmune diseases
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
MX2019015744A (en) Pharmaceutical compositions.
NZ726859A (en) Synthesis of polycyclic-carbamoylpyridone compounds
MX2017014035A (en) Solid forms.
MX2020006237A (en) Compounds for treatment of diseases related to dux4 expression.
CR20200154A (en) Enantiomers of substituted thiazoles as antiviral compounds
MX2017007377A (en) Organic compounds.
PH12016501613B1 (en) Pyrazines modulators of gpr6
MX2019004182A (en) Process for the manufacture of 2,6-dimethyl-5-hepten-1-al.
IN2014MU00916A (en)
WO2019040105A3 (en) Compounds, salts thereof and their use in the treatment of diseases
IN2014CH00304A (en)
EA201790321A1 (en) ELASTOMERIC COMPOSITIONS CONTAINING UNCONNECTIC ACID AND PRODUCTS MADE FROM THEM OR COVERED BY THEM
MX2020012065A (en) Cyclopentane compounds.
MX2016013588A (en) Sitagliptin tannate complex.